The top 25 loci from methylation array data of BE progressors vs NPs (sorted by the lowest to highest P value). Target location_annotation, location of the array probe (Intra, intragenic; Pro, within promoter; Extra, extragenic) and annotation of the loci; NP, nonprogressor; Mean, average of all NPs or of all Ps; P, progressor; P/NP ratio, ratio of means of Ps to means of NPs; 'P value: Student's t-test value of NP group vs P group. When this 
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is highly overexpressed in most malignant tissues, where it functions as an anti-apoptotic agent by enhancing cell survival (Ewing & Goff 2010) . Similarly, TLX3, a HOX11 gene family homeobox member encoding a DNAbinding nuclear transcription factor, is overexpressed in T-cell leukemias and associated with a poor prognosis (Attarbaschi et al. 2009 ). It was the third most significant (PZ0.000073) and 0.313-fold hypomethylated in Ps vs NPs. JUND, another hypomethylated and the tenth most significant gene, is a well-known proto-oncogene and functional component of the AP1 transcription factor complex that has been proposed to protect cells from p53-dependent senescence and apoptosis (Weitzman et al. 2000) . The methylation status of TLX3, IGFIR and JUND in the P and NP samples that were studied by microarray analysis was confirmed by real-time methylation-specific PCR (qMSP) assays, using loci-specific primers and probes (data not shown).
Next, using prediction analysis of microarrays (PAM), we constructed a classifier to distinguish Ps from NPs based on the complete set of methylation array data. Interestingly, PAM classified all the samples correctly except for P4, which was consistently misclassified as a NP. We then inspected the clinical data on patient P4. We noticed that the time interval between sample collection and progression in patient P4 was 40 months. Thus, P4 had been obtained before the pre-progression 'window' of 2 years, the earliest time point at which previously studied methylation marker levels have been shown to begin to change (Schulmann et al. 2005) . In contrast, the remaining four progressors had pre-progression intervals ranging from 16 to 31 months, closer to or within the previously reported 24-month window.
We next inspected the complete methylation array data for methylation levels of specific genes in individual P and NP specimens. Results of this inspection are illustrated in Table 2 . This table illustrates that many of the genes in P4 exhibited methylation levels intermediate between those of the other Ps and those of the NPs. For example, genes highlighted in orange were less hypomethylated in P4 than in the other progressors. Conversely, genes highlighted in blue were less hypermethylated in P4 than in the other progressors. By contrast, there were other genes for which P4 perfectly matched the remaining progressors. For example, genes highlighted in green were just as hypomethylated in P4 as in the other progressors; and genes highlighted in pink were just as hypermethylated in P4 as in the other progressors. Thus, some genes (the green and pink genes) appeared to be good early predictors of progression, while others (the orange and blue genes) tended to change their methylation levels later, i.e. temporally closer to the progression endpoint. We reasoned that 'late-demethylator' genes or loci (such as Pro_RAX) could represent hypomethylation events occurring closer to the progression endpoint, while 'early-demethylator' genes or loci (such as Pro_ITGB8) could become hypomethylated at longer time intervals prior to progression. Similarly, 'latemethylator' genes or loci (such as Intra_PSCD3) were seen to potentially represent hypermethylation events occurring later in Barrett's neoplasia (BN), i.e. closer to the progression endpoint, while 'early-methylator' genes or loci (such as Pro_WDR5) were hypothesized to become hypermethylated at longer time intervals before progression. A graphic illustration of this concept is provided in Fig. 1 .
By using comprehensive methylation microarrays, we were able to seek and find genes that became hypomethylated earlier, even as early as 40 months, prior to progression. Similarly, although P4 was an 'outlier' for loci that became hypermethylated during progression (Fig. 1b) , methylation microarrays enabled us to find genes that became hypermethylated in P4 at 40 months prior to progression (pink gene, Fig. 1b) .
Next, we attempted to verify this late-vs earlymethylator/demethylator hypothesis by applying hierarchical clustering to methylation array data from our five progressor specimens, using Statistica (v. 7.0; Statsoft, Tulsa, OK, USA). Hierarchical clustering revealed two principal branches in these data: one main branch containing samples P1, P2, P3, and P5; and the other main branch consisting entirely of the outlier sample P4 (data not shown). Thus, P4 per se appeared, on a global basis, to constitute a category that differed markedly from the remaining four progressors.
Furthermore, we sought to identify ontologic gene groupings. We applied GOstat (http://gostat.wehi.edu. au/cgi-bin/goStat.pl) to determine which gene ontology terms were over-or under-represented in genes whose promoter regions were differentially methylated in the outlier specimen P4 vs the remaining four Ps. Differential methylation in this analysis was defined by the following two criteria: 1) the difference in the log 2 intensity ratio of P4 vs the mean of P1, P2, P3, and P5 had to be above 0.5 (i.e. equivalent to a 1.4-fold nonlog change); and 2) the log 2 intensity ratio of the outlier P4 had to lie outside the 99% confidence intervals of the mean for samples P1, P2, P3, and P5. GOstat then identified Gene Ontologies that were significantly overrepresented in P4 (the 'orange' genes) relative to all genes whose promoter regions were analyzed in our methylation array analysis. Several of these ontologic categories related to organ development, system development, or multicellular organismal development. Figure 1 (a) Sample ('slice') of the temporal epigenomic program of Barrett's pre-progression, focusing on hypomethylation. X-axis, pre-progression interval of progressor samples or nonprogressors (NPs). Y-axis, methylation index. Orange bars (rear) represent genes, such as RAX, which are consistently and significantly less methylated in progressors than in NPs, except for the outlier sample P4. Green bars (front) signify genes, such as ITGB8, that are hypomethylated in all progressors relative to NPs, including sample P4 (interval to progression Z40.13 months). (b) Sample ('slice') of the temporal epigenomic program of Barrett's preprogression, focusing on hypermethylation. X-axis, pre-progression interval of progressor samples or NPs. Y-axis, methylation index. Blue bars (front) identify loci, such as Intra_PSCD3, which are consistently and significantly more heavily methylated in progressors than in NPs, except for the outlier sample P4. Pink bars (rear) denote genes, such as WDR5, that are hypermethylated in all progressors relative to NPs, including sample P4 (interval to progressionZ40.13 months).
As a caveat, we did not employ multiple testing correction, thus some of the observed differences could have occurred by chance. Moreover, distinguishing characteristics of sample P4 besides its pre-progression interval, such as smoking or therapeutic exposure, could have contributed to the uniqueness of this sample. Nevertheless, based on the above findings, it is tempting to speculate that during the transition from early to late pre-progression, the epigenomic program 'switches' to become dominated by aberrant organ development. Another insight into this process, as mentioned above, is the observed dominance of hypomethylation over hypermethylation in the epigenomic program of BE pre-progression. 
